Delve Health’s upper management is currently attending the Drug Information Association’s (DIA) 2022 Global Annual Meeting in Chicago, Illinois. While we are taking all the necessary precautions to avoid the spread of COVID-19, we are very happy to be on the ground and in-person for this meeting, after a two-year absence. We hadn’t been on-site long and we’ve already had some very interesting and informative conversations with fellow attendees, one of which was regarding the “pros” of virtual research organizations (CROs), such as Delve Health, and the “cons” of traditional CROs.
Conversations On the Ground—Traditional CROs vs. Virtual CROs
Connect with Us
Recent Posts
Designing Patient-Centric Trials with ePRO/eCOA Technologies
September 1, 2025 No Comments
Read More » Evaluating the ROI of Implementing ePRO/eCOA in Clinical Trials
August 28, 2025 No Comments
Read More » Services
Related articles
Delve Health’s Wearable-as-a-Service: Revolutionize Your Clinical Trials
Enabling wearable as a service for clinical trials to reduce costs and improve real world evidence creation.